Burden of disease and cost-effectiveness estimates
Poor water quality continues to pose a major threat to human health. Diarrhoeal disease alone amounts to an estimated 4.1 % of the total DALY global burden of disease and is responsible for the deaths of 1.8 million people every year (WHO, 2004). It was estimated that 88% of that burden is attributable to unsafe water supply, sanitation and hygiene and is mostly concentrated on children in developing countries.
A significant amount of disease could be prevented especially in developing countries through better access to safe water supply, adequate sanitation facilities and better hygiene practices. In order to allow informed decision-making on interventions aimed at disease prevention and control, it is crucial to carry out a sound economic evaluation of the various options available in specific settings.
WHO has undertaken a cost-effectiveness analysis - using the standard methodology developed by WHO - and a cost-benefit analysis at the global level. The costs, the health benefits and the additional benefits of a range of selected interventions to improve water and sanitation services were assessed for each of the 14 WHO sub-regions.
- The costs of the interventions included the full investment and annual recurrent costs.
- In the cost-effectiveness analysis, the health benefits were presented in DALYs averted.
- In the cost-benefit analysis, total benefits of the interventions included time savings due to easier access, gain in productive time and treatment costs saved due to less illness, and the value of prevented deaths.
WHO is currently involved in the development of practical guidance to objectively assess at national level the burden of water-related diseases and the total costs and benefits of improving access to safe water supply and sanitation.